Imidafenacin
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
4-(2-methyl-1H-imidazol-1-yl)-2,2-diphenylbutanamide | |
Clinical data | |
Legal status | ℞ Prescription only |
Routes | Oral |
Identifiers | |
CAS number | 170105-16-5 |
ATC code | None |
PubChem | CID 6433090 |
ChemSpider | 4938278 |
UNII | XJR8Y07LJO |
Chemical data | |
Formula | C20H21N3O |
Mol. mass | 319.40 g/mol |
SMILES
| |
| |
(what is this?) (verify) | |
Imidafenacin (INN) is a urinary antispasmodic of the anticholinergic class.
References
- Kobayashi F, Yageta Y, Segawa M, Matsuzawa S (2007). "Effects of imidafenacin (KRP-197/ONO-8025), a new anti-cholinergic agent, on muscarinic acetylcholine receptors. High affinities for M3 and M1 receptor subtypes and selectivity for urinary bladder over salivary gland". Arzneimittelforschung 57 (2): 92–100. doi:10.1055/s-0031-1296589. PMID 17396619.
- Miyachi H, Kiyota H, Uchiki H, Segawa M (June 1999). "Synthesis and antimuscarinic activity of a series of 4-(1-Imidazolyl)-2,2-diphenylbutyramides: discovery of potent and subtype-selective antimuscarinic agents". Bioorg. Med. Chem. 7 (6): 1151–61. doi:10.1016/S0968-0896(99)00003-6. PMID 10428387.
|
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.